Success Stories

Latest Issue of OR Manager
May 2024
Home Success Stories

Session: Designing a sustainable model for your future OR

Editor’s Note Michelle Larson, DNP, RN, NE-BC, Nurse Administrator at Mayo Clinic, posed this quote from Dr Charles Mayo, founder of the Mayo Clinic, when opening the session, “Designing a Sustainable Model for your Future OR Today”: “If we excel in anything, it is in our capacity for translating idealism…

Read More

By: Bridget Brown
February 7, 2023
Share

Submit presentation proposal for OR Manager Conference 2023 by Dec. 15

Editor's Note The OR Manager Conference program committee is seeking presentation proposals for the 2023 conference, to be held September 18–20 at Music City Center in Nashville, Tennessee. Perioperative leaders who have experience or a story to share in the following categories are encouraged to submit a proposal by December…

Read More

By: Carrie Shapiro
November 30, 2022
Share

Session: ASC Leadership Roundtable Panel, Ask the Experts

Editor's Note The last day of the OR Manager Conference saw perhaps its most inventive breakout session yet. The ambulatory surgery center (ASC) leadership roundtable panel led attendees through an education-filled hour marked by games, interaction, and trivia. “Technology is the way of the future, it is here, and we…

Read More

By: Tarsilla Moura
October 20, 2022
Share

Keynote: Culture CPR, Administer Immediately to Survive the Great Resignation

Editor's Note  Jeff Whitehorn, LFACHE, ACC, founder of Whitehorn Coaching and Consulting, concluded the OR Manager Conference on Wednesday, October 19, by discussing culture CPR—the acronym which, as he explained, stands for Celebration, Passion, and Recognition—as well as best practices for successfully retaining staff. Healthcare lost 20% of its workforce,…

Read More

By: Lauren McCaffrey
October 20, 2022
Share

Sponsored Message

Benefits seen in phase 3 of Alzheimer's drug trial

Editor's Note Eisai, the Japanese drug maker, said on Tuesday September 27, that its experimental drug for Alzheimer’s disease helped slow cognitive decline to those experiencing early stages of the illness. In the phase 3 clinical trials, the drug, called lecanemab, slowed cognitive decline by 27% after 18 months, the…

Read More

By: Lauren McCaffrey
September 28, 2022
Share

Tom Gronow: Realigning OR priorities to focus on the patient

Challenging situations have the potential to bring out the best in people. Tom Gronow, EdD, MHA, president and CEO of UCHealth University of Colorado Hospital (UCH), is a prime example of stepping up when faced with adversity. Gronow spoke to OR Manager about his role and journey at UCHealth. He…

Read More

By: Stephanie Wright, RN, BSN
September 27, 2022
Share

Sponsored Message

Cancer death rates drop as treatments and screening improves

Editor's Note Strides have been made in cancer treatments, diagnostic tools and prevention strategies, driving down cancer death rates, according to a report published Wednesday, September 21, by the American Association for Cancer Research, NBC News September 21 reports. According to the group’s annual Cancer Progress Report, over the past…

Read More

By: Lauren McCaffrey
September 22, 2022
Share

Study: Rubber bands enhance surgical mask seal akin to N95 protection

Editor's Note In this recent study, titled “A simple surgical mask modification to pass N95 respirator-equivalent fit testing standards during the COVID-19 pandemic” and published by PLOS ONE on August 24, the use of rubber bands worn over standard 3-layer surgical masks is shown to improve the mask’s protective seal…

Read More

By: Tarsilla Moura
September 1, 2022
Share

Research shows new antibody protection against malaria

Editor's Note  US government researchers found that lab-engineered antibody has protected the majority of participants from the malaria parasite, including those who received a higher dosage of the antibody, US News & World August 4 reports. The antibody can also be given with a standard injection, instead of the typical…

Read More

By: Lauren McCaffrey
August 4, 2022
Share

Plasma RNA being used to monitor cancer treatment

Editor's Note  According to a May 2022 study from UCLA Health, liquid biopsies for certain cancers are becoming more popular because they are less invasive, Healthcare Purchasing News July 18 reports. This method can be used to monitor cancer treatment and accurately evaluate effectiveness. In this study, UCLA researchers studied…

Read More

By: Lauren McCaffrey
July 19, 2022
Share
Live chat by BoldChat